Blood markers may predict dangerous MS relapses after drug stop
NCT ID NCT05828901
First seen May 13, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study aimed to see if measuring certain proteins on immune cells could predict whether multiple sclerosis (MS) patients would have a relapse or a severe "rebound" after stopping the drug ozanimod. Researchers planned to follow 23 adults with relapsing-remitting MS, taking blood samples and doing MRI scans before and after starting or stopping treatment. The study was terminated early, so results are limited, but the goal was to find a way to identify patients at higher risk of disease flare-ups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurology department
Bern, 3010, Switzerland
Conditions
Explore the condition pages connected to this study.